Title
Category
Credits
Event date
Cost
  • AMA PRA Category 1 Credit™
  • Ethics
  • Participation
$0.00
This two-part video series addresses the ethical issues surrounding confidentiality. Practical tips for navigating social media as a physician.
  • AMA PRA Category 1 Credit™
  • Ethics
  • Participation
$0.00
The first video addresses the implicit bias providers have towards their patients. The second video provides resources for when patients exhibit bias towards the provider.
  • AMA PRA Category 1 Credit™
  • Ethics
  • Participation
$0.00
This two-part video series addresses issues surrounding the ethics end-of-life care. It provides guidance for providers to discuss end-of-life issues with patients that are healthy and patients who are terminal. Tips for discussing end-of-life with patient’s families are provided.
  • AMA PRA Category 1 Credit™
  • Ethics
  • Participation
$0.00
This video addresses the ethical issues surrounding genetics and genetics testing. Practical tips for physicians to consider when ordering, interpreting, and speaking with patients about their genetic tests results.
  • AMA PRA Category 1 Credit™
  • Ethics
  • Participation
$0.00
In this two-part video presentation, you will learn about communicating across cultures, using an interpreter effectively, empathetic listening, the structural barriers that keep patients from seeking medical care, and stereotypes in medicine and how to address them in your own practice.
  • AMA PRA Category 1 Credit™
  • Attendance
01/31/2023
$0.00
NEEDS STATEMENTDigital Pathology is an emerging technology that is not widely known outside of the pathology community. This activity will allow both clinicians and researchers to maximize their time and improve patient care.TARGET AUDIENCEClinicians, pathologists, and researchers
  • AMA PRA Category 1 Credit™
  • Attendance
03/25/2023
$1.00
Needs StatementThis symposium will bring together recognized national and international speakers to address recent advances in diagnosis of myelodysplastic syndrome (MDS) and measurable residual disease [MRD] directed acute myelogenous leukemia (AML) therapy. During our symposium, we will emphasize the need for physicians to combine up-to-date knowledge and technology to efficiently identify “actionable targets” for treatment of AML and MDS patients.
  • ABIM MOC II
  • AMA PRA Category 1 Credit™
  • ANCC
  • Attendance
  • Ethics
03/25/2023
$1.00
In-person ConferenceMarch 25, 2023 - March 26, 2023The Westin Houston Medical CenterLive-stream option available. Registration will close on March 23rd, 2023 at 5:00 PM CT.
  • ABA MOC II
  • ABIM MOC II
  • ABMS MOC II
  • ABOHNS MOC II
  • ABO MOC II
  • ABPath MOC II
  • ABP MOC II
  • ABS MOC II
  • AMA PRA Category 1 Credit™
  • ANCC
  • Attendance
04/25/2023
$1.00
Now Accepting AbstractsAbstract submission is open to faculty, health professionals, trainees, and students.All abstracts will be peer reviewed by faculty experts in quality improvement and patient safety. The faculty and trainee authors of the most highly-rated abstracts will be selected for oral presentations during the conference.The author of accepted abstracts not selected for oral presentations will be invited to present their findings during the poster session.Submission Deadline: Sunday, February 19, 2023, 11:59 PM

Pages